DAIC

JUNE 28, 2024

milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovascular disease.

Kidney Disease 111

Kidney Disease Blood Pressure Cardiovascular Disease Hypertension 111

Cardiometabolic Health Congress

JULY 10, 2024

Bakris , an internationally recognized and influential nephrologist and hypertension expert, who passed away on June 15, 2024, at the age of 72. Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52

Heart BMJ

OCTOBER 10, 2024

Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Accordingly, the management of AF has shifted towards a holistic and integrated approach, targeting comorbidities and risk factors, itself associated with improved outcomes. 2 Before the. 2 Before the.

Atrial Fibrillation 59

Atrial Fibrillation Risk Factors Kidney Disease Heart Failure 59

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

Journal of the American Heart Association

MARCH 21, 2025

Prevalence of hypertension (86.6%), heart failure (22.7%), diabetes (54.8%), chronic kidney disease (23.6%), and chronic obstructive pulmonary disease (35.4%) was high. Ongoing studies will yield important insights regarding improving care and outcomes in this highrisk group. At 1 year, 9.4% of patients had died.

Peripheral Arterial Disease 45

Peripheral Arterial Disease Outcomes Myocardial Infarction Kidney Disease 45

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 100

Education Innovation Risk Factors Obesity 100

Journal of the American Heart Association

MARCH 27, 2025

The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Open Heart

JULY 17, 2023

This study aimed to identify predictors of worse clinical outcome after deferral of non-emergency cardiovascular interventions. Arterial hypertension (HR 2.27; 95% CI 1.00 to 5.12; p=0.049), chronic kidney disease (HR 1.89; 95% CI 1.03 to 3.49; p=0.041) as well as severe valvular heart disease (HR 3.08; 95% CI 1.68

COVID-19 52

COVID-19 Outcomes Cardiovascular Interventions Risk Factors 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Circulation

NOVEMBER 11, 2024

This study evaluates the outcomes in patients admitted for HF with and without hyperkalemia.Methods:We used the Nationwide Readmissions Database (NRD) from 2016-2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year. vs. 2.5%, p < 0.001). 2], p<0.001).Conclusion:Hyperkalemia

Inpatient 40

Inpatient Heart Failure Outcomes Cardiac Arrest 40

Circulation

NOVEMBER 11, 2024

Evaluate the benefit in important cardiovascular outcomes and safety in elderly patients of a blood pressure control ≤ 130mmHg compared to standard of care.Methods:The research was performed in PubMed, EMBASE, Scielo, LILACS, and Cochrane Central Register of Controlled Trials (CENTRAL) from January 1st, 2013 to May 1st, 2023.

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi.

Cardiogenic Shock 40

Cardiogenic Shock Stroke Strokes Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

vs 63.38, p<0.001) and had fewer comorbidities such as cancer and chronic kidney disease, atrial fibrillation, hypertension, hyperlipidemia. We observed an increasing trend of ICH among pregnant individuals. Pregnant patients were notably younger (30.63 vs 16.2%, p<0.001). vs 23.2%, p<0.001).

Hemorrhage 40

Hemorrhage Outcomes Kidney Disease Atrial Fibrillation 40

Open Heart

JUNE 1, 2022

Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE). to 0.97; p=0.02).

Heart Failure 52

Heart Failure Kidney Disease Atrial Fibrillation Hypertension 52

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Preeclampsia (PE) is associated with subsequent higher risk of cardiovascular and kidney disease. Serum copeptin, as a proxy for vasopressin, and urinary uromodulin, were associated with PE physiopathology and kidney functional mass respectively.

Blood Pressure 64

Blood Pressure Kidney Disease Hypertension Hospital 64

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). Nevertheless, data concerning the impact of anemia and ID on clinical outcome in patients with CS are scarce.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life. Key contributions: Advanced cardiac imaging (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

European Journal of Heart Failure

NOVEMBER 23, 2023

Abstract Aims Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease. Albuminuria is common in heart failure and associated with worse outcomes, but its prevalence and relationship to outcome in ATTR-CA remains unclear.

Kidney Disease 40

Kidney Disease Article Biomarkers Heart Failure 40

Circulation

NOVEMBER 11, 2024

The primary exposure variable was 5-HTP levels, and the primary outcome was the severity of coronary calcification assessed through fluoroscopy. to 1.63); hypertension 1.57 (0.87 to 2.31); chronic kidney disease 1.07 (0.33 High 5-HTP levels were significantly associated with more severe calcification (p = 0.04, OR = 3.3,

Kidney Disease 40

Kidney Disease Risk Factors Pharmacology Diabetes 40

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

New guidelines also: Classify “Elevated BP” between non-elevated BP and hypertension. Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Advise increased potassium intake for hypertensive patients. Watch here! Read the published study.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Cardiometabolic Health Congress

JULY 17, 2024

Join us as we examine the landmark approvals that are revolutionizing patient outcomes. Notes: Approved after initial rejection two years prior based on safety data from Japan, where the drug had been used since 2020 It can only be used in kidney disease patients on dialysis for at least 3 months.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundClinical outcome of ischemic cardiogenic shock (CS) requiring extracorporeal membrane oxygenation is highly variable, necessitating appropriate assessment of prognosis. Journal of the American Heart Association, Ahead of Print. However, a systemic predictive model estimating the mortality of refractory ischemic CS is lacking.

Cardiogenic Shock 45

Cardiogenic Shock Hospital Myocardial Infarction Kidney Disease 45

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Cardiometabolic Health Congress

NOVEMBER 8, 2023

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. The virtual, self-paced Foundations of Cardiometabolic Health Certificate Course is the first step to attaining the CCHP credential.

Certification 52

Certification Nursing Kidney Disease Education 52

Stroke Journal

FEBRUARY 1, 2024

We compared demographics, hospital traits, comorbidities, and outcomes. In-hospital mortality, our primary outcome, was analyzed through multivariate logistic regression using STATA 18.Results:Incorporating to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27

Inpatient 40

Inpatient Stroke Strokes Coronary Artery Disease 40

Stroke Journal

JANUARY 30, 2025

Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025. Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients.

Atrial Fibrillation 40

Atrial Fibrillation Hemorrhage Risk Factors Kidney Disease 40

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

They concluded that early rhythm control therapy was associated with a lower risk of adverse cardiovascular outcomes than usual care among patients with early atrial fibrillation and cardiovascular conditions. The study was stopped for efficacy at the third interim analysis after a median of 5.1 years of follow up per patient.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Liraglutide and cardiovascular outcomes in type 2 diabetes.” Neal, Bruce, et al. 2017): 644-657. 2016): 311-322.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Physiologically Speaking

DECEMBER 15, 2023

Participating in any resistance training is associated with a 15%–17% lower risk for these outcomes compared to non-participation. Most data suggest that 30–60 minutes per week is sufficient to maximize the risk reduction — benefits start to plateau and then reverse after this threshold.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

Participating in any resistance training is associated with a 15%–17% lower risk for these outcomes compared to non-participation. Most data suggest that 30–60 minutes per week is sufficient to maximize the risk reduction — benefits start to plateau and then reverse after this threshold.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Dr. Smith's ECG Blog

APRIL 8, 2016

He also had a history of chronic kidney disease, stage III. Angio had shown some acute disease in the saphenous vein graft to the posterior descending artery off of the RCA. The patient stabilized and had a good outcome. Most recent echo showed EF of 60%. He had recently had a NonSTEMI. There is atrial fibrillation.

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Open Heart

DECEMBER 23, 2024

Background Hypertension is a risk factor for bleeding events and is included in the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs/Alcohol concomitantly) score.

Blood Pressure 40

Blood Pressure Peripheral Arterial Disease Kidney Disease Laboratory 40

Stroke Journal

JANUARY 30, 2025

Introduction:Chronic kidney disease (CKD) is a risk factor for intracerebral hemorrhage (ICH) and for worse outcomes following ICH. For each patient, eGFR along with age, sex, race, ethnicity, hypertension, diabetes (DM), heart disease, and hyperlipidemia were abstracted.

Kidney Disease 40

Kidney Disease Hemorrhage Risk Factors Heart Disease 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Chronic kidney disease (CKD) is a risk factor for intracerebral hemorrhage (ICH) and for worse outcomes following ICH. For each patient, eGFR (estimated glomerular filtration rate) along with age, sex, race, ethnicity, hypertension (HTN), diabetes (DM), heart disease, and hyperlipidemia were abstracted.

Kidney Disease 40

Kidney Disease Hemorrhage Risk Factors Biomarkers 40

Open Heart

OCTOBER 21, 2022

We studied incidence, outcomes and temporal trends following PCI-related coronary artery perforation (CAP). Perforation risk factors derived using meta-regression were female sex, hypertension, chronic kidney disease and previous coronary bypass grafting.

Outcomes 52

Outcomes Stents Stent Kidney Disease 52

Circulation

NOVEMBER 11, 2024

Background:Patients with adult congenital heart disease (ACHD) form a unique subset of patients with complex ventricular tachycardia (VT).Objective:To The primary composite outcome was recurrent monomorphic VT, and repeat ablation.Results:Out of 508 procedures for ventricular tachycardia ablation, 37 were performed in ACHD patients.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Tachycardia Heart Disease 40